Detalhe da pesquisa
1.
Prognostic impact and causality of age on oncological outcomes in women with endometrial cancer: a multimethod analysis of the randomised PORTEC-1, PORTEC-2, and PORTEC-3 trials.
Lancet Oncol
; 2024 Apr 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38701815
2.
PORTEC-4a: international randomized trial of molecular profile-based adjuvant treatment for women with high-intermediate risk endometrial cancer.
Int J Gynecol Cancer
; 30(12): 2002-2007, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33046573
3.
Selecting Adjuvant Treatment for Endometrial Carcinoma Using Molecular Risk Factors.
Curr Oncol Rep
; 21(9): 83, 2019 07 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-31367798
4.
Molecular Classification Predicts Response to Radiotherapy in the Randomized PORTEC-1 and PORTEC-2 Trials for Early-Stage Endometrioid Endometrial Cancer.
J Clin Oncol
; 41(27): 4369-4380, 2023 09 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37487144
5.
Radiation Therapy Techniques and Treatment-Related Toxicity in the PORTEC-3 Trial: Comparison of 3-Dimensional Conformal Radiation Therapy Versus Intensity-Modulated Radiation Therapy.
Int J Radiat Oncol Biol Phys
; 112(2): 390-399, 2022 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34610387